245 related articles for article (PubMed ID: 25410364)
1. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases in the CNS: interferons get nervous.
Chopra S; Overall CM; Dufour A
Cell Mol Life Sci; 2019 Aug; 76(16):3083-3095. PubMed ID: 31165203
[TBL] [Abstract][Full Text] [Related]
5. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
Hida Y; Hamada J
Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
[TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinases: How Much Can They Do?
Ågren MS; Auf dem Keller U
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
[TBL] [Abstract][Full Text] [Related]
8. Perspectives and New Aspects of Metalloproteinases' Inhibitors in the Therapy of CNS Disorders: From Chemistry to Medicine.
Boguszewska-Czubara A; Budzynska B; Skalicka-Wozniak K; Kurzepa J
Curr Med Chem; 2019; 26(18):3208-3224. PubMed ID: 29756562
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a role of matrix metalloproteinases and their inhibitors in primordial germ cell migration.
Díez-Torre A; Díaz-Núñez M; Eguizábal C; Silván U; Aréchaga J
Andrology; 2013 Sep; 1(5):779-86. PubMed ID: 23843195
[TBL] [Abstract][Full Text] [Related]
10. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
Lee MH; Rapti M; Knaüper V; Murphy G
J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
[TBL] [Abstract][Full Text] [Related]
11. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
Shukla V; Kumar Shakya A; Dhole TN; Misra UK
Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
Leppert D; Lindberg RL; Kappos L; Leib SL
Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
[TBL] [Abstract][Full Text] [Related]
13. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
Nagase H; Brew K
Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.
Pagenstecher A; Stalder AK; Kincaid CL; Shapiro SD; Campbell IL
Am J Pathol; 1998 Mar; 152(3):729-41. PubMed ID: 9502415
[TBL] [Abstract][Full Text] [Related]
15. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
16. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma.
Napoli S; Scuderi C; Gattuso G; Bella VD; Candido S; Basile MS; Libra M; Falzone L
Cells; 2020 May; 9(5):. PubMed ID: 32392801
[TBL] [Abstract][Full Text] [Related]
17. Clinical Investigation of Matrix Metalloproteinases, Tissue Inhibitors of Matrix Metalloproteinases, and Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Complexes and Their Networks in Apical Periodontitis.
Martinho FC; Teixeira FF; Cardoso FG; Ferreira NS; Nascimento GG; Carvalho CA; Valera MC
J Endod; 2016 Jul; 42(7):1082-8. PubMed ID: 27188765
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their inhibitors in Fuchs endothelial corneal dystrophy.
Xu I; Thériault M; Brunette I; Rochette PJ; Proulx S
Exp Eye Res; 2021 Apr; 205():108500. PubMed ID: 33617849
[TBL] [Abstract][Full Text] [Related]
19. Ischemic-Reperfusion Injury Increases Matrix Metalloproteinases and Tissue Metalloproteinase Inhibitors in Fetal Sheep Brain.
Chen X; Patra A; Sadowska GB; Stonestreet BS
Dev Neurosci; 2018; 40(3):234-245. PubMed ID: 30048980
[TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system.
Gardner J; Ghorpade A
J Neurosci Res; 2003 Dec; 74(6):801-6. PubMed ID: 14648584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
